Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: oral

Currently viewing:

Administrative data

Endpoint:
sub-chronic toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
14 days
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
test procedure in accordance with generally accepted scientific standards and described in sufficient detail

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2007
Report date:
2007

Materials and methods

Test guideline
Version / remarks:
no guideline available
Principles of method if other than guideline:
dietary administration of isopropyl myristate for 14 days in rats, results should be used for a subsequent 90 day sub-chronic study in rats
GLP compliance:
not specified

Test material

Constituent 1
Test material form:
liquid
Specific details on test material used for the study:
Isopropyl myristate supplied by Allan Chemical Corporation, Fort Lee, New Jersey (lot "070102805)

Test animals

Species:
rat
Strain:
other: F344/DUCRL
Details on species / strain selection:
8 weeks old, healthy, females nulliparous and non-pregnant, supplied by Charles River Laboratories Inc. (Kingston, New York)
Sex:
male/female
Details on test animals or test system and environmental conditions:
Housing: One rat per cage, stainless steel cages with a wire mesh floor and suspended above absorbent paper, temperature 22+/- 1°C, humidity. 40-70%, air changes: 12-15 times/hour, photoperiod: 12 hours light/dark
Feed and water: LabDiet Certified Rodent Diet, municipal water ad libitum
Identification by subcutaneously implanted transponders

Administration / exposure

Route of administration:
oral: feed
Vehicle:
unchanged (no vehicle)
Details on oral exposure:
diets mixed weekly and dietary concentrations adjusted basesd upon the recent body weight and feed consumption data
Analytical verification of doses or concentrations:
yes
Duration of treatment / exposure:
14 days
Doses / concentrationsopen allclose all
Dose / conc.:
0 mg/kg bw/day (nominal)
Dose / conc.:
125 mg/kg bw/day (nominal)
Dose / conc.:
250 mg/kg bw/day (nominal)
Dose / conc.:
500 mg/kg bw/day (nominal)
Dose / conc.:
750 mg/kg bw/day (nominal)
Dose / conc.:
1 000 mg/kg bw/day (nominal)
No. of animals per sex per dose:
5 rats/sex/dose = 60 rats on study
Control animals:
yes
yes, concurrent no treatment
Positive control:
no

Examinations

Observations and examinations performed and frequency:
daily: cage-side examination, twice weekly: body weight, feed consumption, weekly: clinical observations (hand-held), calculation of test material intake, statistics
Sacrifice and pathology:
all animals killed on day 15 of the experiment
Other examinations:
no
Statistics:
mean body weight and body weight gain, feed consumption, test material intake

Results and discussion

Results of examinations

Clinical signs:
no effects observed
Mortality:
no mortality observed
Body weight and weight changes:
no effects observed
Food consumption and compound intake (if feeding study):
no effects observed
Food efficiency:
not examined
Water consumption and compound intake (if drinking water study):
not examined
Ophthalmological findings:
not examined
Haematological findings:
not examined
Clinical biochemistry findings:
not examined
Urinalysis findings:
not examined
Behaviour (functional findings):
no effects observed
Immunological findings:
not examined
Organ weight findings including organ / body weight ratios:
not examined
Gross pathological findings:
not examined
Neuropathological findings:
not examined
Histopathological findings: non-neoplastic:
not examined
Histopathological findings: neoplastic:
not examined
Other effects:
no effects observed

Effect levels

Dose descriptor:
NOEL
Effect level:
> 1 000 mg/kg bw/day (nominal)
Based on:
test mat.
Sex:
male/female
Remarks on result:
not determinable because of methodological limitations

Target system / organ toxicity

Critical effects observed:
no

Applicant's summary and conclusion

Conclusions:
Under the conditions of this study, isopropyl myristate was palatable to F344/DuCRL rats given up to 1000 mg/kg bw/ day for 14 days.